Implications of urine F2-isoprostane metabolite concentration in horses with colic and its potential use as a predictor for surgical intervention

E. Noschka, S. R. Werre, M. V. Crisman, Craig Thatcher, G. L. Milne, L. A. Dahlgren

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Reasons for performing study: F2-isoprostanes have been used extensively to quantify lipid peroxidation in association with risk factors in various diseases. Horses with colic may have intestinal ischaemia and/or inflammation characterised by oxidative stress and increased production of isoprostanes. Objectives: To gather preliminary data regarding the feasibility of using urine F2-isoprostanes and isoprostane metabolites as early screening tools for the presence of gastrointestinal disease requiring surgical intervention in horses and ultimately develop a stall-side test capable of identifying these horses as early as possible for timely referral. Methods: Concentrations of urine isoprostane and isoprostane metabolite were determined by mass spectroscopy and normalised to urine creatinine (Cr) concentrations in urine samples from 42 healthy control horses and 43 horses with gastrointestinal pain or colic. Results: Horses with colic were treated medically (n = 21) or surgically (n = 22). Mean ± s.d. concentrations of urine isoprostane and isoprostane metabolite were significantly higher in horses with colic (2.94 ± 1.69 and 0.31 ± 0.22ng/mg Cr, respectively), compared to control horses (1.89 ± 1.39 and 0.22 ± 0.08ng/mg Cr, respectively). Mean urine isoprostane metabolite concentrations were significantly higher in horses undergoing surgery (0.38 ± 0.28ng/mg Cr) compared to controls and medical colics (0.26 ± 0.11ng/mg Cr). Nonsurvivors had significantly higher mean urine isoprostane metabolite concentrations (0.47 ± 0.39ng/mg Cr) than control or surviving colic horses (0.29 ± 0.24ng/mg Cr). Conclusions: Measurement of urine isoprostane metabolite concentration may be a useful prognostic indicator in equine colic. Potential relevance: Urine isoprostane metabolites may aid in early recognition of surgical colic. Isoprostanes are a potential therapeutic target to prevent further systemic and gastrointestinal tissue injury in horses with colic.

Original languageEnglish (US)
Pages (from-to)34-41
Number of pages8
JournalEquine Veterinary Journal
Volume43
Issue numberSUPPL.39
DOIs
StatePublished - Aug 2011

Fingerprint

F2-Isoprostanes
Isoprostanes
Colic
colic
Horses
urine
Urine
metabolites
horses
creatinine
Creatinine
Gastrointestinal Diseases
ischemia
digestive system diseases
Lipid Peroxidation

Keywords

  • Colic
  • Horse
  • Isoprostanes
  • Predictor
  • Survival

ASJC Scopus subject areas

  • Equine

Cite this

Implications of urine F2-isoprostane metabolite concentration in horses with colic and its potential use as a predictor for surgical intervention. / Noschka, E.; Werre, S. R.; Crisman, M. V.; Thatcher, Craig; Milne, G. L.; Dahlgren, L. A.

In: Equine Veterinary Journal, Vol. 43, No. SUPPL.39, 08.2011, p. 34-41.

Research output: Contribution to journalArticle

Noschka, E. ; Werre, S. R. ; Crisman, M. V. ; Thatcher, Craig ; Milne, G. L. ; Dahlgren, L. A. / Implications of urine F2-isoprostane metabolite concentration in horses with colic and its potential use as a predictor for surgical intervention. In: Equine Veterinary Journal. 2011 ; Vol. 43, No. SUPPL.39. pp. 34-41.
@article{9b463e85f58c43649a0b1a7933bd0c7c,
title = "Implications of urine F2-isoprostane metabolite concentration in horses with colic and its potential use as a predictor for surgical intervention",
abstract = "Reasons for performing study: F2-isoprostanes have been used extensively to quantify lipid peroxidation in association with risk factors in various diseases. Horses with colic may have intestinal ischaemia and/or inflammation characterised by oxidative stress and increased production of isoprostanes. Objectives: To gather preliminary data regarding the feasibility of using urine F2-isoprostanes and isoprostane metabolites as early screening tools for the presence of gastrointestinal disease requiring surgical intervention in horses and ultimately develop a stall-side test capable of identifying these horses as early as possible for timely referral. Methods: Concentrations of urine isoprostane and isoprostane metabolite were determined by mass spectroscopy and normalised to urine creatinine (Cr) concentrations in urine samples from 42 healthy control horses and 43 horses with gastrointestinal pain or colic. Results: Horses with colic were treated medically (n = 21) or surgically (n = 22). Mean ± s.d. concentrations of urine isoprostane and isoprostane metabolite were significantly higher in horses with colic (2.94 ± 1.69 and 0.31 ± 0.22ng/mg Cr, respectively), compared to control horses (1.89 ± 1.39 and 0.22 ± 0.08ng/mg Cr, respectively). Mean urine isoprostane metabolite concentrations were significantly higher in horses undergoing surgery (0.38 ± 0.28ng/mg Cr) compared to controls and medical colics (0.26 ± 0.11ng/mg Cr). Nonsurvivors had significantly higher mean urine isoprostane metabolite concentrations (0.47 ± 0.39ng/mg Cr) than control or surviving colic horses (0.29 ± 0.24ng/mg Cr). Conclusions: Measurement of urine isoprostane metabolite concentration may be a useful prognostic indicator in equine colic. Potential relevance: Urine isoprostane metabolites may aid in early recognition of surgical colic. Isoprostanes are a potential therapeutic target to prevent further systemic and gastrointestinal tissue injury in horses with colic.",
keywords = "Colic, Horse, Isoprostanes, Predictor, Survival",
author = "E. Noschka and Werre, {S. R.} and Crisman, {M. V.} and Craig Thatcher and Milne, {G. L.} and Dahlgren, {L. A.}",
year = "2011",
month = "8",
doi = "10.1111/j.2042-3306.2011.00384.x",
language = "English (US)",
volume = "43",
pages = "34--41",
journal = "Equine veterinary journal. Supplement",
issn = "2042-3306",
publisher = "British Equine Veterinary Association",
number = "SUPPL.39",

}

TY - JOUR

T1 - Implications of urine F2-isoprostane metabolite concentration in horses with colic and its potential use as a predictor for surgical intervention

AU - Noschka, E.

AU - Werre, S. R.

AU - Crisman, M. V.

AU - Thatcher, Craig

AU - Milne, G. L.

AU - Dahlgren, L. A.

PY - 2011/8

Y1 - 2011/8

N2 - Reasons for performing study: F2-isoprostanes have been used extensively to quantify lipid peroxidation in association with risk factors in various diseases. Horses with colic may have intestinal ischaemia and/or inflammation characterised by oxidative stress and increased production of isoprostanes. Objectives: To gather preliminary data regarding the feasibility of using urine F2-isoprostanes and isoprostane metabolites as early screening tools for the presence of gastrointestinal disease requiring surgical intervention in horses and ultimately develop a stall-side test capable of identifying these horses as early as possible for timely referral. Methods: Concentrations of urine isoprostane and isoprostane metabolite were determined by mass spectroscopy and normalised to urine creatinine (Cr) concentrations in urine samples from 42 healthy control horses and 43 horses with gastrointestinal pain or colic. Results: Horses with colic were treated medically (n = 21) or surgically (n = 22). Mean ± s.d. concentrations of urine isoprostane and isoprostane metabolite were significantly higher in horses with colic (2.94 ± 1.69 and 0.31 ± 0.22ng/mg Cr, respectively), compared to control horses (1.89 ± 1.39 and 0.22 ± 0.08ng/mg Cr, respectively). Mean urine isoprostane metabolite concentrations were significantly higher in horses undergoing surgery (0.38 ± 0.28ng/mg Cr) compared to controls and medical colics (0.26 ± 0.11ng/mg Cr). Nonsurvivors had significantly higher mean urine isoprostane metabolite concentrations (0.47 ± 0.39ng/mg Cr) than control or surviving colic horses (0.29 ± 0.24ng/mg Cr). Conclusions: Measurement of urine isoprostane metabolite concentration may be a useful prognostic indicator in equine colic. Potential relevance: Urine isoprostane metabolites may aid in early recognition of surgical colic. Isoprostanes are a potential therapeutic target to prevent further systemic and gastrointestinal tissue injury in horses with colic.

AB - Reasons for performing study: F2-isoprostanes have been used extensively to quantify lipid peroxidation in association with risk factors in various diseases. Horses with colic may have intestinal ischaemia and/or inflammation characterised by oxidative stress and increased production of isoprostanes. Objectives: To gather preliminary data regarding the feasibility of using urine F2-isoprostanes and isoprostane metabolites as early screening tools for the presence of gastrointestinal disease requiring surgical intervention in horses and ultimately develop a stall-side test capable of identifying these horses as early as possible for timely referral. Methods: Concentrations of urine isoprostane and isoprostane metabolite were determined by mass spectroscopy and normalised to urine creatinine (Cr) concentrations in urine samples from 42 healthy control horses and 43 horses with gastrointestinal pain or colic. Results: Horses with colic were treated medically (n = 21) or surgically (n = 22). Mean ± s.d. concentrations of urine isoprostane and isoprostane metabolite were significantly higher in horses with colic (2.94 ± 1.69 and 0.31 ± 0.22ng/mg Cr, respectively), compared to control horses (1.89 ± 1.39 and 0.22 ± 0.08ng/mg Cr, respectively). Mean urine isoprostane metabolite concentrations were significantly higher in horses undergoing surgery (0.38 ± 0.28ng/mg Cr) compared to controls and medical colics (0.26 ± 0.11ng/mg Cr). Nonsurvivors had significantly higher mean urine isoprostane metabolite concentrations (0.47 ± 0.39ng/mg Cr) than control or surviving colic horses (0.29 ± 0.24ng/mg Cr). Conclusions: Measurement of urine isoprostane metabolite concentration may be a useful prognostic indicator in equine colic. Potential relevance: Urine isoprostane metabolites may aid in early recognition of surgical colic. Isoprostanes are a potential therapeutic target to prevent further systemic and gastrointestinal tissue injury in horses with colic.

KW - Colic

KW - Horse

KW - Isoprostanes

KW - Predictor

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=79960710045&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960710045&partnerID=8YFLogxK

U2 - 10.1111/j.2042-3306.2011.00384.x

DO - 10.1111/j.2042-3306.2011.00384.x

M3 - Article

C2 - 21790752

AN - SCOPUS:79960710045

VL - 43

SP - 34

EP - 41

JO - Equine veterinary journal. Supplement

JF - Equine veterinary journal. Supplement

SN - 2042-3306

IS - SUPPL.39

ER -